Oramed reports 1Q loss
Oramed Pharmaceuticals posts loss of $2.6 million in 1st quarter
JERUSALEM (AP) _ Oramed Pharmaceuticals Inc. (ORMP) on Wednesday reported a loss of $2.6 million in its fiscal first quarter.
On a per-share basis, the Jerusalem-based company said it had a loss of 20 cents.
The drug maker posted revenue of $610,000 in the period.
Oramed shares have risen nearly 7 percent since the beginning of the year. The stock has decreased 9 percent in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORMP at https://www.zacks.com/ap/ORMP
_____
Keywords: Oramed Pharmaceuticals, Earnings Report